BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 18253111)

  • 1. Persistent prostatic hematuria.
    Rastinehad AR; Ost MC; VanderBrink BA; Siegel DN; Kavoussi LR
    Nat Clin Pract Urol; 2008 Mar; 5(3):159-65. PubMed ID: 18253111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective arterial prostatic embolization (SAPE) for refractory hematuria of prostatic origin.
    Rastinehad AR; Caplin DM; Ost MC; VanderBrink BA; Lobko I; Badlani GH; Weiss GH; Kavoussi LR; Siegel DN
    Urology; 2008 Feb; 71(2):181-4. PubMed ID: 18308078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of gross hematuria secondary to prostatic bleeding with finasteride.
    Sieber PR; Rommel FM; Huffnagle HW; Breslin JA; Agusta VE; Harpster LE
    J Urol; 1998 Apr; 159(4):1232-3. PubMed ID: 9507842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of benign prostatic hyperplasia.
    Edwards JL
    Am Fam Physician; 2008 May; 77(10):1403-10. PubMed ID: 18533373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-coital gross hematuria: an unusual presentation of benign prostatic hyperplasia.
    Chen YH; Lin PY; Cheng YS; Lin JS; Lin YM
    Asian J Androl; 2007 Nov; 9(6):856-8. PubMed ID: 17968474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic Artery Embolization in Refractory Hematuria of Prostatic Origin.
    Kably I; Acharya V; Richardson AJ; Bhatia S
    Tech Vasc Interv Radiol; 2020 Sep; 23(3):100694. PubMed ID: 33308527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate Artery Embolization Used in the Management of Transfusion-Dependent Hematuria After Prostatic Urethral Lift Procedure in a Patient with Thrombocytopenia: A Case Report.
    Spradling K; Deb S; Brubaker WD; Gill H; Conti S
    J Endourol Case Rep; 2020; 6(3):238-240. PubMed ID: 33102736
    [No Abstract]   [Full Text] [Related]  

  • 9. Prostate Artery Embolization (PAE) in the Management of Refractory Hematuria of Prostatic Origin Secondary to Iatrogenic Urological Trauma: A Safe and Effective Technique.
    Kably I; Pereira K; Chong W; Bhatia S
    Urology; 2016 Feb; 88():218-21. PubMed ID: 26610676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5alpha-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction.
    Rittmaster RS
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):389-402. PubMed ID: 18471794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current role of transcatheter arterial embolization for bladder and prostate hemorrhage.
    Loffroy R; Pottecher P; Cherblanc V; Favelier S; Estivalet L; Koutlidis N; Moulin M; Cercueil JP; Cormier L; Krausé D
    Diagn Interv Imaging; 2014 Nov; 95(11):1027-34. PubMed ID: 24746761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Successful intra-arterial embolization of bleeding carcinoma of the prostate (author's transl)].
    Bischoff W; Goerttler U
    Urologe A; 1977 Mar; 16(2):99-102. PubMed ID: 855061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urogenital cytology and surgical decision making. A differential diagnostic approach to hematuria, stranguria, and prostatomegaly.
    Allen SW
    Probl Vet Med; 1989; 1(1):1-15. PubMed ID: 2520094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic Arterial Embolization for Control of Hematuria in Patients with Advanced Prostate Cancer.
    Chen JW; Shin JH; Tsao TF; Ko HG; Yoon HK; Han KC; Thamtorawat S; Hong B
    J Vasc Interv Radiol; 2017 Feb; 28(2):295-301. PubMed ID: 28110760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of prostate artery embolization in the management of refractory haematuria of prostatic origin.
    Pereira K; Halpern JA; McClure TD; Lewis NA; Kably I; Bhatia S; Hu JC
    BJU Int; 2016 Sep; 118(3):359-65. PubMed ID: 27153766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-Alpha reductase inhibitors--benign prostatic hypertrophy and much more].
    Holzgrabe U; Bennack E
    Pharm Unserer Zeit; 2008; 37(4):310-4. PubMed ID: 18570285
    [No Abstract]   [Full Text] [Related]  

  • 17. 5alpha-Reductase inhibitor treatment of prostatic diseases: background and practical implications.
    Dörsam J; Altwein J
    Prostate Cancer Prostatic Dis; 2009; 12(2):130-6. PubMed ID: 19030020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of delaying 5-alpha reductase inhibitor therapy in men on alpha-blocker therapy to treat BPH: assessment of acute urinary retention and prostate-related surgery.
    Naslund M; Eaddy MT; Hogue SL; Kruep EJ; Shah MB
    Curr Med Res Opin; 2009 Nov; 25(11):2663-9. PubMed ID: 19757985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dutasteride on the efficacy of photoselective vaporization of the prostate: results of a randomized, placebo-controlled, double-blind study (DOP trial).
    Bepple JL; Barone BB; Eure G
    Urology; 2009 Nov; 74(5):1101-4. PubMed ID: 19800668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of finasteride treatment on suburethral prostatic microvessel density in patients with hematuria related to benign prostate hyperplasia.
    Memis A; Ozden C; Ozdal OL; Guzel O; Han O; Seckin S
    Urol Int; 2008; 80(2):177-80. PubMed ID: 18362489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.